CIS1, a cytokine-inducible SH2 protein, suppresses BCR/ABL-mediated transformation: Involvement of the ubiquitin proteasome pathway

This publication has 15 references indexed in Scilit:

• Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: Involvement of the ubiquitin proteosome pathway
  Experimental Hematology, 1999
• Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice
  Molecular and Cellular Biology, 1999
• The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
  The EMBO Journal, 1999
• Cloning and Characterization of Novel CIS Family Genes
  Biochemical and Biophysical Research Communications, 1997
• Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3
  Biochemical and Biophysical Research Communications, 1997
• Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
  The Journal of Experimental Medicine, 1994
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.
  Proceedings of the National Academy of Sciences, 1988
• The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity
  Virology, 1985
• An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
  Cell, 1984